Indevus Pharmaceuticals, Inc.

Indevus

Indevus Pharmaceuticals is a publicly-traded biotechnology company focusing on developing and commercializing speciality pharmaceuticals. Through internal R&D and strategic partnerships, it is advancing the state-of-art of drug delivery with its innovative Hydron Implant technology. Indevus was acquired by Endo Pharmaceuticals (NASDAQ: ENDP).

Company Website

Business Category

Healthcare - Biotech, Life Sciences

Investment Status

Acquired